News
Endpoints
|
21st September 2023
Endpoints 11 2023: Feng Zhang bets on solving gene therapy’s biggest problem: ‘Delivery is such a big bottleneck’
Read More
Biotech Week Boston
|
19th September 2023
2023 Start-up of the Year Winner
Read More
Bloomberg
|
22nd February 2023
A Refreshing Gamble on Crispr Delivery
Read More
STAT
|
16th February 2023
CRISPR pioneer Feng Zhang launches new genetic delivery startup with $193 million
Read More
Endpoints
|
16th February 2023
‘Rare outliers’: Feng Zhang eyes a new path to genetic medicine delivery with ex-Alnylam leaders and $193M
Read More
Insider
|
16th February 2023
CRISPR pioneer Feng Zhang plans to ‘break open the barrier’ facing gene editing after raising $193 million for his secretive new startup
Read More
Boston Globe
|
16th February 2023
Investors bet big on Feng Zhang’s new startup, out to solve one of gene editing’s most vexing problems
Read More